These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 399243

  • 1. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH.
    Infection; 1979; 7 Suppl 6():527-31. PubMed ID: 399243
    [Abstract] [Full Text] [Related]

  • 2. [The antibacterial efficacy of cefaclor against bacteria resistant to ampicillin, tetracycline and co-trimoxazole (author's transl)].
    Machka K.
    Infection; 1979; 7 Suppl 6():536-9. PubMed ID: 399244
    [Abstract] [Full Text] [Related]

  • 3. [The antibacterial efficacy of cefaclor in routine testing of clinical material from two Berlin hospitals (author's transl)].
    Wagner J, Hahn H.
    Infection; 1979; 7 Suppl 6():547-50. PubMed ID: 121730
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of four recently introduced cephalosporins with respect to probability of resistance in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. (author's transl)].
    Loch R, Schröter G.
    Zentralbl Bakteriol Orig A; 1979; 245(3):312-6. PubMed ID: 44785
    [Abstract] [Full Text] [Related]

  • 5. [The distribution of minimal inhibitory concentrations of recently introduced cephalosporins in multiresistant strains of Escherichia coli, Proteus mirabilis and Klebsiella spec. as revealed by zone sizes of a standardized agar diffusion test (author's transl)].
    Schröter G, Loch R.
    Zentralbl Bakteriol Orig A; 1979; 245(3):317-23. PubMed ID: 44786
    [Abstract] [Full Text] [Related]

  • 6. [Antibacterial activity of cefotaxim in comparison with seven cephalosporins].
    Braveny I, Dickert H, Machka K.
    Infection; 1979; 7(5):231-6. PubMed ID: 389804
    [Abstract] [Full Text] [Related]

  • 7. [In vitro activity of cefaclor (author's transl)].
    Knothe H.
    Infection; 1979; 7 Suppl 6():518-26. PubMed ID: 45087
    [Abstract] [Full Text] [Related]

  • 8. Variable in vitro activity of cefaclor, cephalothin and cefadroxil against Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
    Larsson P, Lincoln K, Lind L, Sandberg T.
    Scand J Infect Dis; 1988; 20(4):421-4. PubMed ID: 3057617
    [Abstract] [Full Text] [Related]

  • 9. Comparison of in vitro antibacterial activity of four oral cephems: cephalexin, cefaclor, cefatrizine and cefadroxil.
    Luh KT, Chao HP, Ho SW, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1984 Feb; 17(1):11-8. PubMed ID: 6378550
    [Abstract] [Full Text] [Related]

  • 10. [In vitro examination on antibacterial activities of broad-spectrum antibiotics against gram-negative clinical isolates (author's transl)].
    Deguchi K, Oda S, Sato Y, Ikeda Y, Nakamura T.
    Jpn J Antibiot; 1975 Dec; 28(6):785-94. PubMed ID: 1104913
    [Abstract] [Full Text] [Related]

  • 11. Antimicrobial activity in vitro of cefaclor, a new oral cephalosporin.
    Meyers BR, Hirschman SZ.
    J Clin Pharmacol; 1978 Dec; 18(2-3):85-90. PubMed ID: 624778
    [Abstract] [Full Text] [Related]

  • 12. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics.
    George WL, Lewis RP, Meyer RD.
    Antimicrob Agents Chemother; 1978 Mar; 13(3):484-9. PubMed ID: 122524
    [Abstract] [Full Text] [Related]

  • 13. In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
    Kamimura T, Kojo H, Matsumoto Y, Mine Y, Goto S, Kuwahara S.
    Antimicrob Agents Chemother; 1984 Jan; 25(1):98-104. PubMed ID: 6561017
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility of clinical isolates of gram-negative bacilli.
    Siebert WT, Williams TW.
    South Med J; 1975 Aug; 68(8):963-9. PubMed ID: 169593
    [Abstract] [Full Text] [Related]

  • 15. Susceptibility of "enterobacteria" to penicillins, cephalosporins, lincomycins, erythromycin, and rifampin.
    Finland M, Garner C, Wilcox C, Sabath LD.
    J Infect Dis; 1976 Aug; 134 Suppl():S75-96. PubMed ID: 823280
    [Abstract] [Full Text] [Related]

  • 16. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ, Washington JA.
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [Abstract] [Full Text] [Related]

  • 17. [Antibiotic sensitivity of bacteria isolated from the urine of children with urinary tract infections from 1986 to 1995].
    Lazarević G, Petreska D, Pavlović S.
    Srp Arh Celok Lek; 1998 Mar; 126(11-12):423-9. PubMed ID: 9921014
    [Abstract] [Full Text] [Related]

  • 18. Correlation of beta-lactamase production and resistance to beta-lactam antibiotics in Enterobacteriaceae.
    Cullmann W, Flensberg T, Opferkuch W, Stieglitz M, Wiedemann B.
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):480-9. PubMed ID: 6758422
    [Abstract] [Full Text] [Related]

  • 19. In vitro susceptibility of selected bacteria to cefaclor.
    Valenti AJ, Andriole VT.
    Yale J Biol Med; 1977 Sep; 50(5):465-9. PubMed ID: 341537
    [Abstract] [Full Text] [Related]

  • 20. A comparative study of the activity of cefamandole and other cephalosporins and analysis of the beta-lactamase stability and synergy of cefamandole with aminoglycosides.
    Fu KP, Neu HC.
    J Infect Dis; 1978 May; 137 Suppl():S38-S50. PubMed ID: 349097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.